Live News EARNINGS ARTICLE L impact Aug 03, 2026, 08:19 PM UTC

GeneDx Holdings Affirms FY2026 Sales Guidance of $475.000M-$490.000M vs $478.367M Est

GeneDx Holdings (NASDAQ: WGS ) affirms FY2026 sales outlook from $475.000 million-$490.000 million to $475.000 million-$490.000 million vs $478.367 million estimate.

WGS

SquawkNews Newsroom

GeneDx Holdings (NASDAQ: WGS ) affirms FY2026 sales outlook from $475.000 million-$490.000 million to $475.000 million-$490.000 million vs $478.367 million estimate.